This inventor holds 1 USPTO granted patent. Top assignee: Genzyme Corporation. Active years: 1997.
Company Filing History:
Years Active: 1997
Title: Edward George Bemstine: Innovator in Human Fertility Hormones
Introduction
Edward George Bemstine is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of human fertility hormones. His innovative work has led to advancements that may benefit reproductive health.
Latest Patents
Edward George Bemstine holds a patent for "Recombinant heterodimeric human fertility hormones, and methods, cells." This patent describes biologically active heterodimeric human fertility hormones composed of two different subunits. Each subunit is synthesized in the same cell transformed by at least one cell expression vector containing heterologous DNA encoding each subunit, with each subunit being controlled by a separate promoter. The preferred human fertility hormones include hCG, hLH, and hFSH. He has 1 patent to his name.
Career Highlights
Bemstine has had a distinguished career, working at Genzyme Corporation, a leading biotechnology company. His role at Genzyme has allowed him to focus on innovative research and development in the field of human fertility.
Collaborations
Throughout his career, Edward has collaborated with notable colleagues, including Anton K Beck and Nancy Hsiung. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Edward George Bemstine is a prominent figure in the field of biotechnology, particularly in the area of human fertility hormones. His innovative patent and work at Genzyme Corporation highlight his contributions to reproductive health. His collaborations with esteemed colleagues further emphasize the impact of his research in this vital field.